Stryker Orthopedics has shown sluggish financial growth according to economic experts, which could in part be due to the company’s recalled metal-on-metal hip replacements. The company earned less than projected while also announcing a metal hip lawsuit settlement of more than $1.4 billion.
Stryker issued a hip replacement recall for its Rejuvenate and ABG II metal hip implants in 2012 after studies showed the devices were much more likely to fail and cause complications than alternative implants. Patients soon began filing Stryker hip replacement lawsuits against the company alleging that the defective devices led to injuries.
Stryker recently announced the $1.4 billion hip settlement, which should cover thousands of patients who were injured by the Rejuvenate and ABG II. More patients are expected to join the settlement after suffering from complications due to their Stryker hip replacement, including tissue damage, premature loosening of the hip joint and toxic levels of metal in the blood stream.